Viewing Study NCT00906360


Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2025-12-30 @ 6:17 AM
Study NCT ID: NCT00906360
Status: TERMINATED
Last Update Posted: 2013-07-02
First Post: 2009-05-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module